FDA warned Ariella Naturals that its website sells unapproved mole and skin tag removal drugs without FDA approval.
What happened
In August 2022, FDA reviewed tryariella.com and found the company takes orders for two Ariella skin tag and mole removal products. FDA said website claims, including before-and-after photos and promises that skin tags or moles fall off in days to weeks, show the products are intended to treat disease or affect the body. FDA said there are no legally marketed OTC drugs for mole or skin tag removal and warned that self-treatment can delay cancer diagnosis and cause injuries or scarring.
What FDA found
The products are drugs because the website claims they remove skin tags and moles and affect the body.
FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)The products are new drugs because they are not generally recognized as safe and effective for those uses.
FD&C Act section 201(p), 21 U.S.C. 321(p)The products were offered for sale without an FDA-approved application.
FD&C Act sections 505(a) and 301(d), 21 U.S.C. 355(a) and 331(d)
What FDA wants
FDA asks the company to notify it in writing within fifteen working days of receipt, describing steps taken to address the violations and prevent recurrence, with related documentation. If corrective actions cannot be completed in that time, the company must state the reason and the time within which it will do so.
Who should pay attention
- online sellers of skin-care and beauty products
- companies marketing mole or skin-tag removal products
- regulatory teams reviewing website claims for drugs
This is a summary. Read the original letter on fda.gov.